Vaidya Sane Ayurved Laboratories Ltd

Vaidya Sane Ayurved Laboratories Ltd

₹ 206 -1.90%
25 Apr - close price
About

Incorporated in 2006, Vaidya Sane Ayurved Laboratories Ltd is the business of running
of hospitals & clinics, and sale of Ayurved based medicines[1]

Key Points

Business Overview:[1][2][3]
VSALL is a chain of Cardiac Care Clinics and hospitals that have 350+ Clinics, out of these 54 are company-owned, 62 are OPD’s Mini Clinic and 234 are franchised clinics. These are run by 450+ Ayurvedic Physicians. Company also has 2 hospitals viz. Madhavbaug Hospital, Khopoli (NABH Accredited) and Madhavbaug Hospital Nagpur.

  • Market Cap 217 Cr.
  • Current Price 206
  • High / Low 377 / 172
  • Stock P/E 83.3
  • Book Value 39.0
  • Dividend Yield 0.24 %
  • ROCE 19.9 %
  • ROE 13.5 %
  • Face Value 10.0

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 13.7% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023
31 43 46 54 50
29 39 41 50 48
Operating Profit 3 4 4 4 2
OPM % 8% 10% 10% 7% 4%
0 0 1 1 0
Interest 0 0 0 0 0
Depreciation 1 1 1 1 2
Profit before tax 1 3 4 3 1
Tax % -2% 38% 25% 25% 25%
1 2 3 2 0
EPS in Rs 1.94 2.01 2.86 2.07 0.40
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
62 75 52 74 99 104
59 72 48 67 90 98
Operating Profit 3 3 4 7 9 6
OPM % 5% 4% 9% 10% 9% 5%
0 0 -1 0 1 1
Interest 1 1 1 1 1 0
Depreciation 2 2 2 2 3 3
Profit before tax 1 -0 0 5 7 3
Tax % 44% -24% 16% 27% 25%
0 -1 0 3 5 3
EPS in Rs 111.11 -124.44 86.67 3.30 4.94 2.47
Dividend Payout % 0% 0% 0% 0% 5%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 10%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 124%
TTM: -49%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -13%
Return on Equity
10 Years: %
5 Years: %
3 Years: 14%
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 0 0 0 11 11 11
Reserves 9 8 10 25 30 30
9 6 1 1 0 4
11 15 15 13 14 25
Total Liabilities 29 29 26 50 55 70
16 16 17 17 21 21
CWIP 2 4 0 1 2 2
Investments 0 0 0 21 15 14
11 10 8 10 18 33
Total Assets 29 29 26 50 55 70

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
2 8 6 -13 -0
-10 -4 -1 -8 1
8 -4 -5 22 -1
Net Cash Flow -1 0 -0 2 -1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 21 12 19 18 24
Inventory Days 77 49 35
Days Payable 138 138 147
Cash Conversion Cycle -39 -77 -93 18 24
Working Capital Days -7 -26 -46 -25 2
ROCE % 5% 17% 22% 20%

Shareholding Pattern

Numbers in percentages

Mar 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34%
33.67% 33.66% 33.68% 33.67% 33.67% 33.66% 33.66% 33.66%
No. of Shareholders 493464534595637731846881

Documents